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ABSTRACT - Embryo quality is influenced by the culture conditions that affect in vitro maturation (IVM), fertilization
(IVF) and culture (IVC) rates. The present study investigated the feasibility of producing bovine embryos after the
replacement of fetal calf serum (FCS) and bovine serum albumin (BSA) by ovalbumin (OVA). The IVM and IVC medium
were supplemented with 10% FCS, 4 mg/mL BSA, or 4 mg/mL OVA. The IVF medium was supplemented with 6 mg/mL BSA
or OVA. For IVM, supplementation with FCS, BSA, and OVA did not affect nuclear maturation or cortical granule migration.
Higher rates of formation of two pronuclei were obtained when FCS was employed for IVM (79.97%), regardless of the
supplement used for IVF, and when BSA was used for IVF (59.4%), regardless of the supplement used for IVM.
Supplementation with OVA for IVM+IVC (20.40%) and for IVF (22.15%) was inferior to supplementation with FCS for
IVM+IVC (30.47%) and with BSA for IVF (28.91%) for blastocyst development. Hatching rates were lower using OVA for
IVM+IVC (23.02%) and for IVF (28.93%) compared with FCS and BSA under the same conditions (40.78 and 34.82%,
respectively) and BSA for IVF (36.82%). Supplementation with OVA for IVM+IVC and IVF resulted in reduced inner cell
mass, trophectoderm cells and total blastocyst cell numbers (17.29, 37.88, and 55.17, respectively). In conclusion, OVA
is a protein source for bovine in vitro embryo production, although the quantity and quality of bovine blastocysts using only
ovalbumin in the entire in vitro production process are lower than those obtained in the presence of FCS and BSA, when
used as supplements in any step of bovine in vitro embryo production.
Key Words: bovine embryo, in vitro culture, ovalbumin, protein source
Revista Brasileira de Zootecnia
© 2011  Sociedade Brasileira de Zootecnia
ISSN 1806-9290
www.sbz.org.br
Introduction
In vitro production of bovine embryos enables greater
reproductive use of genetically superior animals and reduces
the interval generation, improving animal breeding.
Thus, studies investigating the three steps of in vitro
embryo production (IVP) are necessary to try to achieve
results comparable to those obtained in vivo.
The culture media used for mammalian embryo
development are conventionally supplemented with fetal
calf serum (FCS) or bovine serum albumin (BSA) (Bavister
et al., 1992; Gardner & Lane, 1993). FCS and BSA are
complex, undefined mixtures of different proteins, which
contain small peptides, energy substrates and growth factors
(Chaudhry et al., 2008, Kane & Headon, 1980; Pratten et al.,
1988). However, because BSA and FCS are prepared and
purified from bovine blood products, they present a high
risk of contamination by pathogens, viruses (Guerin et al.,
1988), and prions (Batt et al., 1991; Krisher et al., 1999).
Thus, alternative supplements have been evaluated to
replace BSA and FCS during IVP in order to avoid cross-
contamination. The most commonly defined supplements
used for IVP are synthetic macromolecules, such as
polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP)
(Takahashi & First, 1992; Wrenzycki et al., 1999). However,
the results are controversial, and the quantity and quality
of the embryos produced are often unsatisfactory.
Therefore, in the present study, ovalbumin (OVA), a
protein source that has not been previously reported for
bovine embryo IVP was evaluated. Ovalbumin, the main
protein component of albumen (54%), is a phosphoprotein
whose synthesis is stimulated by estrogen (Bahr &
Johnson, 1991). Ovalbumin contains all essential amino
acids (Besler & Mine, 1999). Thus, OVA is a protein
supplement that can maintain cell proliferation (Barlian et al.,
1993). In addition, the risks of transmission of diseases to
cattle are lower because of the heterologous (avian) origin
of OVA.
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The objective of the present study was to compare the
effects of OVA and bovine blood proteins (FCS and BSA)
on the IVP. The effects of OVA on nuclear and cytoplasmic
maturation, pronuclear formation, embryo cleavage rates,
blastocyst development, hatching rates and numbers of
cells were carefully investigated.
Material and Methods
Chemicals and media were purchased from Sigma-
Aldrich Chemical Company (St. Louis, MO, USA).
Bovine oocytes were collected by follicular aspiration
from ovaries obtained at a local slaughterhouse and
transported to the laboratory in 0.9% saline at 30-35 ºC.
Follicles measuring 3 to 8 mm in diameter were aspirated
with an 18-gauge needle connected to a 20-mL syringe.
Cumulus-oocyte complexes with at least three cell layers
and homogenous cytoplasm were selected and washed in
HEPES-buffered tissue culture medium 199 (TCM-199;
Gibco-BRL, Grand Island, NY, USA) supplemented with
10% FCS (Crypion, Andradina, Brazil), 0.20 mM sodium
pyruvate, and 83.4 μg/mL amikacin (Instituto Biochimico,
Rio de Janeiro, Brazil).
For IVM, groups of 40-50 oocytes were cultured in
400 μL of TCM-199 containing Earle’s salts (Gibco-BRL),
1.0 μg/mL FSH (FolltropinTM, Bioniche Animal Health,
Belleville, Canada), 50 IU/mL hCG (ProfasiTM, Serono, São
Paulo, Brazil), 1.0 μg/mL estradiol, 0.2 mM sodium pyruvate,
and 83.4 μg/mL amikacin under mineral oil (Dow Corning
Co., Midland, MI, USA) in 4-well dishes (Nunc, Rochester,
NY, USA) for 24 h at 38.5ºC in 5% CO2 in the air. The IVM
medium was supplemented with either 10% FCS, 4 mg/mL
BSA, or 4 mg/mL OVA.
After IVM, oocyte maturation was evaluated based on
the stage of nuclear progression (MII stage) and cortical
granule migration to the periphery of the cytoplasmic
membrane. For this purpose, 1,505 oocytes were divided
into three experimental groups and analyzed in quadruplicate
(334-450 oocytes per treatment).
Oocytes were stained as described by Cherr et al.
(1988). Briefly, cumulus cells were removed with 0.2%
hyaluronidase (Hyalozima™, Aspen, São Paulo, Brazil),
and the zona pellucida was removed with 0.5% pronase and
acid solution (pH 2.5). Oocytes were then fixed in 3%
formaldehyde (Mallinckrodt, Paris, KY, USA) and incubated
in blocking solution (PBS containing 1 mg/mL BSA, 100 mM
glycine [Plusone, La Jolla, CA, USA], and 0.2% sodium
azide), left to sit overnight at 4 ºC. For permeabilization,
oocytes were treated with 0.1% Triton X-100 (USB, Cleveland,
OH, USA) and incubated in 10 μg/mL fluorescein
isothiocyanate-conjugated Lens culinaris agglutinin
and 10 μg/mL Hoechst 33342. Oocytes were then mounted
on slides and examined under an Olympus IX-FLA-70
epifluorescence microscope (Tokyo, Japan) to evaluate
meiotic progression (excitation of 330-385 nm and
emission of 420-490 nm) and the distribution of the
cortical granules (excitation of 460-490 nm and emission
of 515 nm). Images of each oocyte were captured with an
AxioCam camera and stored using AxioVision 4.7.1
software (Carl Zeiss, Jena, Germany). MII oocytes
exhibiting cortical granules homogenously distributed at
the periphery were defined as matured according to the
classification of Hosoe & Shioya (1997).
IVF was performed 24 h after IVM in mineral oil-covered
droplets of 100-μL TALP-IVF medium (TALP medium
supplemented with 30 μg/mL heparin, 18 μM penicillamine,
10 μM hypotaurine and 1.8 μM epinephrine) containing
0.2 mM pyruvate and 83.4 μg/mL amikacin and supplemented
with 6 mg/mL BSA or OVA.
Frozen semen straws (0.5 mL) were thawed in water at
35 oC for 30 s and prepared by centrifugation on a 45% to
90% Percoll gradient at 900 x g for 30 min in TALP-semen
medium (TALP medium supplemented with 10 mM acid
HEPES [J.T. Baker, Phillipsburg, NJ, USA]). A 30-μL aliquot
was taken for evaluation of sperm concentration and motility.
Final concentration was adjusted to 25 × 106 motile
spermatozoa/mL with TALP-IVF medium. Next, 8 μL of
diluted semen were added to the droplets containing 20
to 25 oocytes, for a final concentration of 2 × 105 motile
spermatozoa/droplet (2 × 106/mL), corresponding to
8-10 × 103 spermatozoa per oocyte. Ooocytes were co-
incubated with the sperm for 18 to 20 h at 38.5 oC in an
atmosphere of 5% CO2 in air under saturated humidity. The
semen from the same bull was used for all treatments.
Eighteen to 20 h after the beginning of IVF, the cumulus
cells were removed from the presumptive zygotes by
successive pipetting. Zygotes were stained with 10 μg/mL
Hoechst 33342 for 10 min, and the presence and number of
pronuclei were evaluated under an epifluorescence
microscope (excitation of 330-385 nm and emission of
420-490 nm). For this purpose, 508 presumptive zygotes
were divided into groups, according to experimental design,
and analyzed in quadruplicate (79-90 zygotes per treatment).
After IVF, presumptive zygotes were cultured in 4-well
dishes containing 500 μL of synthetic oviductal fluid (SOF)
supplemented with 10% FCS, 4 mg/mL BSA, or 4  mg/mL
OVA under mineral oil. Dishes were incubated in an
atmosphere of 5% O2, 5% CO2 and 90% N2 at 38.5 °C in a
modular chamber (Billups-Rothenberg, Del Mar, CA, USA)
under saturated humidity for 7 to 9 days.
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Cleavage rate was determined approximately 32 to 36 h
post-insemination under a stereomicroscope (magnification
of 50 X). Cleavage was defined as the presence of two-to-
four-cell embryos. Development toward blastocyst stage
was evaluated on day 7 after IVF. Hatching was evaluated
on day 8 after IVF. Blastocyst rate was calculated based on
number of treated oocytes, and hatching rate was based on
number of blastocysts. For this purpose, 2,355 bovine
oocytes were divided into six experimental groups and
analyzed in five replicates (314-352 oocytes per treatment).
The morphological quality of the blastocysts produced
in vitro was evaluated by the proportion of total cells
allocated to the inner cell mass (ICM) and trophectoderm
(TE). For this purpose, 390 blastocysts derived from six
experimental groups were analyzed in triplicate (52-59
blastocysts per treatment).
Blastocysts were stained according to the technique of
Iwasaki et al. (1990). Briefly, the zona pellucida of the
blastocysts obtained on day 7 was removed by incubation
in 0.5% pronase, followed by incubation in acid solution
(pH 2.5). Next, blastocysts were washed in medium without
FCS and incubated on ice in 10 mM picric acid (ReagenTM,
Rio de Janeiro, Brazil) and 3 mg/mL PVP. Blastocysts were
then incubated in rabbit anti-bovine serum (1:10) at 38.5 °C
for 30 min, followed by incubation in guinea pig complement
(1:10) containing 10 μg/mL propidium iodide and 10 μg/mL
Hoechst 33342 at 38.5 °C for an additional 30 min. Blastocysts
were placed on glass slides, covered with glass coverslips
and examined under an epifluorescence microscope
(excitation of 340-380 nm and emission of 430 nm) to count
the number of ICM cells, whose nuclei were stained blue
with Hoechst 33342, and TE cells, whose nuclei stained pink
with propidium iodide and Hoechst (Koo et al., 2002).
In a preliminary experiment, three concentrations of
OVA were used for IVM. Effects were evaluated by means
of nuclear maturation and cortical granule migration. IVM
medium was supplemented with 2, 4 or 6 mg/mL OVA. Data
from three replicates were used, for a total of 676 oocytes.
In order to determine the effects of supplementation by
different protein sources during the three steps of in vitro
embryo production (IVM, IVF and IVC), an experimental
design was performed. Combinations of the same supplement
for IVM+IVC were combined with BSA or OVA for IVF.
The effect of the source of protein supplementation on
IVM was assessed by supplementing the IVM medium with
10% FCS, 4 mg/mL of BSA or 4 mg/mL of OVA. Oocytes were
evaluated for nuclear maturation and cortical granule
migration in quadruplicate, for a total of 1,168 oocytes.
The effect of treatment on pronuclear formation during
IVF was evaluated using a factorial design, which consisted
of three sources of supplementation during IVM (FCS, BSA
and OVA) and two sources of supplementation during IVF
(BSA and OVA). Three replicates per group were performed,
for a total of 508 oocytes.
For the IVC step, embryo development (cleavage,
blastocyst and hatching rates) and cell number (ICM, TE
and total number) results were determined and analyzed by
a factorial design consisting of three sources of combined
supplementation during IVM and IVC (FCS, BSA and OVA)
and two sources of supplementation during IVF (BSA and
OVA), for a total of six experimental groups. For IVC, five
replicates per group were performed, for a total of 2,003
oocytes. To determine embryo cell number, 324 embryos
were stained (51 to 59 embryos per group).
Nuclear maturation and cortical granule migration
results were analyzed by ANOVA. Pronuclear formation,
embryo development rates (cleavage, blastocyst and
hatching rates), embryo cell numbers, and their interaction
were analyzed by ANOVA. Means were compared by the
Tukey test. The equality of variance was tested by Levene’s
test. Statistical analysis was performed using the Statistical
Analysis System (SAS Institute, Inc., 1989). A level of
significance of 5% was used for all experiments.
Results and Discussion
Appropriate in vitro bovine embryo production (IVP)
systems with high sanitary standards are fundamental in
commercial bovine IVP settings, and they depend largely
on FCS and BSA’s substitution. Especially due to the
preponderance of Nellore in its herd, Brazil has developed
an expertise in bovine biotechnology and has successfully
applied it towards large-scale in vitro bovine embryo
production (Pontes et al. 2009, 2010). For the first time, the
introduction of OVA was proposedas a supplement for
bovine embryo IVP to improve the sanitary quality of
Figure 1 - Schematic of the experimental design used to evaluate
the performance of OVA compared with BSA and
FCS in IVM+IVC and OVA compared with BSA for
IVF of bovine oocytes.
Experimental design
IVF
IVC
IVM
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bovine embryos produced in vitro. The adequate
concentration and the effects of OVA in the three main
steps (IVM, IVF and IVC) of bovine embryo IVP were
evaluated by measuring the formation of pronuclei and
embryo development rates and embryo cell staining.
Different concentrations of ovalbumin (2, 4 or 6 mg/mL)
for the IVM of bovine oocytes were evaluated by assessing
nuclear maturation and cortical granule migration (Table 1).
Similar results were obtained with 4 and 6 mg/mL of
ovalbumin. Four  mg/mL for IVM and for IVC, which are the
same amounts used for BSA, were preferred.
In the next experiment, IVM was performed using
different protein sources (FCS, BSA, OVA), and nuclear
maturation and cortical granule migration were evaluated
(Table 2). For FCS, BSA and OVA, similar rates (P>0.05) of
nuclear maturation (74.01 to 78.78%) and cortical granule
migration (58.89 to 65.48%; Table 2) were observed.
Therefore, we can conclude that OVA, FCS, and BSA
supplementation enables similar nuclear and cytoplasmic
maturation.
To observe the effect of protein source during IVM and
IVF, the rate of pronucleus formation and the number of
pronuclei formed were evaluated 18 to 20 h post-
insemination. No statistical interaction (P>0.05) between
IVM and IVF was observed when different protein sources
were compared. However, higher rates (P<0.05) of two
pronuclei were obtained when FCS was used for IVM
(79.97%) compared with BSA (48.06%) and OVA (38.35%)
and when BSA was used for IVF (59.4%) compared to OVA
(51.52%).
As for the pronuclear formation rates, no interaction
(P>0.05) between IVM+IVC and IVF occurred. Data were
then statistically compared using protein supplementation
for IVM+IVC (FCS [n = 654], BSA [n = 684] and OVA
[n = 665]) and protein supplementation for IVF (BSA
[n = 1006] and OVA [n = 997]).
Cleavage rates were similar (P>0.05) between treatments
when FCS (78.53%), BSA (75.64%) or OVA (69.19%) was
used for IVM+IVF and BSA (76.72%) or OVA (72.18%) was
used for IVF. IVM+IVC supplementation with BSA or
FCS resulted in similar blastocyst rate. Nonetheless, OVA
supplementation during IVM+IVC resulted in lower (P<0.05)
IVM supplement N Nuclear maturation (% ± SD) CG migration (% ± SD)
FCS 3 8 4 75.66 ± 2.88 64.35 ± 5.56
BSA 4 5 0 74.01 ± 4.41 58.89 ± 2.88
OVA 3 3 4 78.78 ± 4.32  65.48 ± 11.50
Tota l 1168  -  -
N = number of oocytes; SD = standard deviation; CG = cortical granules. No significant differences (P>0.05) were observed between in vitro maturation supplements.
Table 2 - Nuclear maturation and cortical granule migration of oocytes matured in vitro for 24 h in medium supplemented with 10%
fetal calf serum (FCS), 4 mg/mL bovine serum albumin (BSA) or 4 mg/mL ovalbumin (OVA)
Ovalbumin (mg/mL) N Nuclear maturation (% ± SD) Cortical granule migration (% ± SD)
2 1 5 9 50.83 ± 8.42b 20.15 ± 2.31b
4 1 6 7 82.66 ± 0.63a 54.21 ± 5.04a
6 1 7 0 77.05 ± 5.82a 47.65 ± 4.16a
Tota l 4 9 6 - -
N = number of oocytes; SD = standard deviation.
a,b = different superscripts within columns indicate differences (P<0.05) between ovalbumin concentrations during IVM.
Table 1 - Nuclear maturation and cortical granule migration after in vitro maturation (IVM) of oocytes for 24 h in medium
supplemented with 2, 4 or 6 mg/ml ovalbumin
Different letters (a, b and a’, b’) above the bars indicate significant differences
(P<0.05) between IVM and IVF supplementation, respectively. Bars depict means,
and whiskers depict standard deviations.
Figure 2 - Rates of the absence of pronuclei (A and B) or the
presence of two pronuclei (C and D) in zygotes
produced from oocytes matured in medium
supplemented with fetal calf serum (FCS), bovine
serum albumin (BSA) or ovalbumin (OVA) (A and C)
or fertilized in medium supplemented with BSA or
OVA (B and D).
IVM supplementation IVF supplementation
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blastocyst (20.40%) and hatching (23.02%) rates than FCS
(30.47 and 40.78% for blastocyst and hatching rates,
respectively) and BSA (25.73 and 34.82% for blastocyst and
hatching rates, respectively) (Figure 3).
Furthermore, the use of OVA during IVF resulted in
lower blastocyst development and hatching rates (22.15%
and 28.93%, respectively) than BSA (28.91 and 36.82% for
blastocyst and hatching rates, respectively).
Because there was interaction between IVM+IVC and
IVF supplementation,  the six experimental groups were
compared using the supplement associations (Table 3).
When OVA was used as the supplement for IVF, the use of
FCS or BSA as supplements during IVM and IVC resulted
in higher (P<0.05) ICM, TE and total cell number compared
with OVA for IVM+IVC. When OVA was used as the
supplement for IVM+IVC, the use of BSA for IVF resulted
in higher (P<0.05) ICM, TE and total cell number compared
with OVA as a supplement for IVF. Therefore,
supplementation with OVA during IVM+IVC and IVF
decreased embryo quality, as measured by the number of
ICM, TE and total cells in bovine blastocysts.
The different in vitro culture systems that support
the development of embryos can be classified according
to the presence or absence of protein sources. Media
supplemented with FCS are considered undefined, media
supplemented with BSA are classified as semi-defined, and
media with synthetic supplements are considered defined
in their composition. Although defined media would be the
ideal system for the in vitro culture of oocytes and embryos,
supplementation of culture media with protein sources of
animal origin provides the best results from oocyte
maturation to the final step of in vitro embryo development
(Vanroose et al., 2001). Synthetic supplements, such as
PVA, PVP and Ficoll, can successfully replace serum during
IVM when IVC is performed using 5 mg/mL of BSA and 2.5%
FCS (Mingoti et al., 2009). Synthetic macromolecules such
as polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP)
have been proposed as substitutes for animal proteins in
embryo culture media, but lower embryo development has
been observed (Lim et al., 2007).
Recently, the use of plant protein hydrolysates or
plant peptones (consisting of oligopeptides and free amino
acids from wheat and cotton) has been evaluated. Even
though similar rates of embryo development were observed,
the embryo sex ratio was skewed towards male embryos
and needs to be clarified (George et al., 2009). In this
study, the aim was to avoid cross-contamination caused by
supplements of bovine origin and evaluate the possibility
of using OVA, a well-characterized protein supplement of
animal origin but with no sanitary risks.
Maturation is complete when the oocyte can be fertilized
and develop into an embryo (Rizos et al., 2003). The analysis
of nuclear maturation and cortical granule migration (a sign
of cytoplasmic maturation) found no significant differences
(P>0.05) between the different protein sources (FCS, BSA,
and OVA). The rate of nuclear maturation ranged from
74.01 to 78.78% in the different groups, and these rates
were similar to the ones reported by other investigators
(approximately 80%) for the IVM of oocytes in an undefined
medium (Kim et al., 1997).
The success of IVF in cattle depends on the appropriate
preparation of both semen and oocytes that favors the
metabolic activity of male and female gametes (Brackett
et al. 1981). Regarding the rate of pronucleus formation and
the number of pronuclei formed, significant differences
were observed in the proportion of the absence of a
pronucleus and the development of two pronuclei. The
capacity of a zygote to form pronuclei depends on the
quality of oocyte maturation, and, in this study, FCS was
the most efficient protein source for IVM, compared with
BSA and OVA. Furthermore, the rate of two pronuclei  when
oocytes were subjected to IVF with BSA was higher than
with OVA, regardless of the supplement used for IVM (FCS,
BSA or OVA).
Variations in embryo development results are observed
among laboratories due to differences in the procedures,
protocols and substances (Gordon, 1994). In the present
experiment, no significant (P>0.05) differences in cleavage
Different letters (a, b and a’, b’) above the bars indicate significant differences
(P<0.05) among the supplements used for IVM+IVC and for IVF, respectively.
Bars depict means, and whiskers depict standard deviations.
Figure 3 - Effect of fetal calf serum (FCS), bovine serum albumin
(BSA) or ovalbumin (OVA) supplementation in IVM
plus IVC medium or in IVF medium on blastocyst
(A and B) and hatching (C and D) rates.
IVM + IVC supplementation IVF supplementation
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rates were observed among treatments. Similar cleavage
rates were reported by Pinyopummintr & Bavister (1994),
who compared semi-defined or undefined culture media
with chemically defined media.
In the literature, the results obtained with BSA and
FCS are controversial. The absence of BSA in SOF during
IVM increased morulae and blastocyst production (Ali &
Sirard 2002), while the presence of BSA-V and FCS during
IVC reduced the percentage of morulae and blastocysts,
compared with the use of purified BSA, fatty acid-free
(FAF) BSA and ovalbumin (Ali & Sirard, 2002). Similarly,
Carolan et al. (1995) reported that the removal of BSA
from the SOF medium during IVC results in significantly
lower blastocyst yields on days 6, 7 and 8. In contrast,
Lonergan et al. (1998) observed that FCS significantly
accelerated embryo development, triggering premature
blastulation and improving blastocyst quality, as
demonstrated by an increased total cell number and
hatching rate. In media containing FCS, hatching is
facilitated by the presence of plasminogen, which assists
in the degradation of the zona pellucida (Kaaekuahiwi &
Menino, 1990). However, prolonged supplementation
with FCS in the culture medium leads to morphological
alterations and has deleterious effects on the embryo,
affecting cell density, color, size, metabolism and the
expression of numerous genes (Krisher et al., 1999;
Shamsuddin & Rodriguez-Martinez, 1994; Hall, 1999).
Additional harmful alterations include ultrastructural
rupture of organelles, such as mitochondria, among others
(Hasler, 2000; Farin et al. 2001). Metabolic alterations,
such as an abnormally large number of lipid droplets in
morulae and blastocysts, have also been reported for embryos
cultured in FCS-supplemented medium compared with
serum-free medium (Abe et al., 1999).
One of the most practical and efficient approaches
to evaluate the embryo quality of blastocysts produced
in vitro is the quantification of the total number of cells in
the embryo and the proportion of cells allocated into the
ICM and TE. Bovine embryos of superior quality should
have a total cell number as close as possible to the number
of cycles. Under the conditions of the present experiment,
this number would range from 64 to 128 cells. Total cell
number ranged from 56.04 to 84.86 cells per embryo for the
treatments using different protein supplement sources.
Given the interval of analysis, this mean was distinctly
lower than what was expected for the chronological age of
the blastocysts.
The use of FCS and BSA during IVM+IVC was efficient
for in vitro embryo production, regardless of the protein
source used during IVF (BSA or OVA). However, OVA
supplementation during all three steps (IVM, IVF and IVC)
resulted in embryos with a smaller total number of cells (<64
cells, corresponding to the sixth cell cycle), which were
classified as low quality. Similar lower embryo quality was
observed when FCS and BSA were replacedby PVA during
IVC. A mean total number of 81 cells for blastocysts was
produced in medium containing FCS, compared with 156
cells for medium supplemented with BSA and 76 cells for
medium containing PVA (Kuran et al., 2001).
Conclusions
The present results show that it is possible to produce
bovine embryos in the absence of FCS or BSA using OVA
as a protein source. Although the quantity and quality of
bovine blastocysts using only OVA throughout IVP were
lower than those obtained in the presence of FCS and BSA,
OVA used during IVF and IVC was able to maintain
blastocyst rate, blastocyst development, and hatching
rates when FCS was used during IVM. Further studies
combining OVA with growth factors, vitamins and
hormones during bovine IVP should be performed to
improve culture conditions and define efficient systems
for bovine embryo IVP.
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